Skip to main content
Erschienen in: International Urology and Nephrology 9/2016

06.06.2016 | Nephrology - Original Paper

Impact of renal involvement on survival in ANCA-associated vasculitis

verfasst von: Manish Rathi, Benzeeta Pinto, Aadhaar Dhooria, Vinay Sagar, Tarun Mittal, Roopa Rajan, Varun Dhir, Susheel Kumar, Kusum Sharma, Ritambhra Nada, Surjit Singh, Ranjana Walker Minz, Aman Sharma

Erschienen in: International Urology and Nephrology | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Renal involvement is a serious complication of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). We describe the pattern of renal involvement and its correlation with outcomes.

Patients and methods

Medical records of 92 patients seen in rheumatology clinic and diagnosed as AAV between January 2007 and June 2014 were analysed. Patients were classified as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA) and undifferentiated AAV. Overall and renal outcomes were analysed. Patients were classified as advanced renal failure (creatinine >5.7 mg/dl or requiring dialysis), deranged RFT not qualifying the above parameters, and normal renal function.

Results

Sixty-seven (72.8 %) patients had GPA, 14 (15.2 %) had MPA, 8 (8.7 %) had EGPA, and 3 (3.3 %) had undifferentiated AAV. Renal involvement was seen in 51 (55.4 %) patients (46.3 % of GPA patients, 78.6 % of MPA, 37.5 % of EGPA and 33.3 % of unclassifiable AAV patients). Renal involvement was more common in males (p = 0.008). Patients with renal involvement had higher mean BVAS scores as compared to patients without renal involvement (p < 0.01). Thirteen patients (25.5 %) presented with advanced renal failure (creatinine >5.7 mg/dl or requiring dialysis), 21 (41.2 %) had deranged renal functions but did not require dialysis, and the rest had proteinuria and active sediments with normal serum creatinine. Twenty-four patients (47.1 %) had good renal outcome with normal creatinine, 12 (23.5 %) had persistent renal insufficiency, 12 (23.5 %) died, and one (2 %) remained dialysis dependent. Mean survival and mortality did not differ in patients with and without renal involvement (p = 0.454, p = 0.388).

Conclusions

Renal involvement was more common in males. BVAS was higher in patients with renal involvement. The mean survival and mortality were similar in patients with or without renal involvement.
Literatur
1.
Zurück zum Zitat Holle JU, Laudien M, Gross WL (2010) Clinical manifestations and treatment of Wegener’s granulomatosis. Rheum Dis Clin North Am 36:507–526CrossRefPubMed Holle JU, Laudien M, Gross WL (2010) Clinical manifestations and treatment of Wegener’s granulomatosis. Rheum Dis Clin North Am 36:507–526CrossRefPubMed
2.
Zurück zum Zitat Sharma A, Gopalakrishan D, Nada R et al (2014) Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades. Int J Rheum Dis 17:562–572PubMed Sharma A, Gopalakrishan D, Nada R et al (2014) Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades. Int J Rheum Dis 17:562–572PubMed
3.
Zurück zum Zitat Sharma A, Mittal T, Rajan R, Rathi M, Nada R, Minz RW, Joshi K, Sakhuja V, Singh S (2014) Validation of the consensus methodology algorithm for the classification of systemic necrotizing vasculitis in Indian patients. Int J Rheum Dis 17:408–411CrossRefPubMed Sharma A, Mittal T, Rajan R, Rathi M, Nada R, Minz RW, Joshi K, Sakhuja V, Singh S (2014) Validation of the consensus methodology algorithm for the classification of systemic necrotizing vasculitis in Indian patients. Int J Rheum Dis 17:408–411CrossRefPubMed
4.
Zurück zum Zitat Villiger PM, Guillevin L (2010) Microscopic polyangiitis: clinical presentation. Autoimmun Rev 9:812–819CrossRefPubMed Villiger PM, Guillevin L (2010) Microscopic polyangiitis: clinical presentation. Autoimmun Rev 9:812–819CrossRefPubMed
5.
Zurück zum Zitat Pagnoux C, Guilpain P, Guillevin L (2007) Churg–Strauss syndrome. Curr Opin Rheumatol 19:25–32CrossRefPubMed Pagnoux C, Guilpain P, Guillevin L (2007) Churg–Strauss syndrome. Curr Opin Rheumatol 19:25–32CrossRefPubMed
6.
Zurück zum Zitat Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107CrossRefPubMed Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107CrossRefPubMed
7.
Zurück zum Zitat Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11CrossRefPubMed Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11CrossRefPubMed
8.
Zurück zum Zitat Suppiah R, Mukhtyar C, Flossmann O, Alberici F, Baslund B, Batra R et al (2011) A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford) 50:899–905CrossRef Suppiah R, Mukhtyar C, Flossmann O, Alberici F, Baslund B, Batra R et al (2011) A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford) 50:899–905CrossRef
9.
Zurück zum Zitat Aasarod K, Iversen BM, Hammerstrom J, Bostad L, Vatten L, Jorstad S (2000) Wegener’s granulomatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant 15:611–618CrossRefPubMed Aasarod K, Iversen BM, Hammerstrom J, Bostad L, Vatten L, Jorstad S (2000) Wegener’s granulomatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant 15:611–618CrossRefPubMed
10.
Zurück zum Zitat Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430CrossRefPubMed Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430CrossRefPubMed
11.
Zurück zum Zitat Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nölle B et al (2000) An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43:1021–1032CrossRefPubMed Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nölle B et al (2000) An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43:1021–1032CrossRefPubMed
12.
Zurück zum Zitat Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M (2009) Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and polyarteritisnodosa. Rheumatology 48:1560–1565CrossRefPubMed Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M (2009) Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and polyarteritisnodosa. Rheumatology 48:1560–1565CrossRefPubMed
13.
Zurück zum Zitat Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG et al (2011) Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology 50:1916–1920CrossRefPubMed Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG et al (2011) Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology 50:1916–1920CrossRefPubMed
14.
Zurück zum Zitat Liu LJ, Chen M, Yu F, Zhao MH, Wang HY (2008) Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology 47:708–712CrossRefPubMed Liu LJ, Chen M, Yu F, Zhao MH, Wang HY (2008) Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology 47:708–712CrossRefPubMed
15.
Zurück zum Zitat Hilhorst M, Wilde B, van Paassen P, Winkens B, van Breda Vriesman P, Tervaert JWC (2013) Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study. Nephrol Dial Transplant 28(2):373–379CrossRefPubMed Hilhorst M, Wilde B, van Paassen P, Winkens B, van Breda Vriesman P, Tervaert JWC (2013) Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study. Nephrol Dial Transplant 28(2):373–379CrossRefPubMed
16.
Zurück zum Zitat Rhee RL, Hogan SL, Poulton CJ, McGregor JA, Landis JR, Falk RJ et al (2016) Trends in long-term outcomes among patients with ANCA-associated vasculitis with renal disease. Arthritis Rheumatol. doi:10.1002/art.39614 PubMed Rhee RL, Hogan SL, Poulton CJ, McGregor JA, Landis JR, Falk RJ et al (2016) Trends in long-term outcomes among patients with ANCA-associated vasculitis with renal disease. Arthritis Rheumatol. doi:10.​1002/​art.​39614 PubMed
17.
Zurück zum Zitat Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Pan-Thames Renal Research Group et al (2003) Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 41:776–784CrossRefPubMed Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Pan-Thames Renal Research Group et al (2003) Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 41:776–784CrossRefPubMed
18.
Zurück zum Zitat de Groot K, Harper L, Jayne DR, Suarez LFF, Gregorini G, Gross WL, EUVAS (European Vasculitis Study Group) et al (2009) Pulse versus daily oral cyclophosphamide for induction of remission in anti-neutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150:670–680CrossRefPubMed de Groot K, Harper L, Jayne DR, Suarez LFF, Gregorini G, Gross WL, EUVAS (European Vasculitis Study Group) et al (2009) Pulse versus daily oral cyclophosphamide for induction of remission in anti-neutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150:670–680CrossRefPubMed
19.
Zurück zum Zitat Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD (2004) ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant 19:1403–1411CrossRefPubMed Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD (2004) ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant 19:1403–1411CrossRefPubMed
20.
Zurück zum Zitat Hauer HA, Bajema IM, Van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, European Vasculitis Study Group (EUVAS) et al (2002) Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 62:1732–1742CrossRefPubMed Hauer HA, Bajema IM, Van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, European Vasculitis Study Group (EUVAS) et al (2002) Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 62:1732–1742CrossRefPubMed
21.
Zurück zum Zitat Yumura W, Kobayashi S, Suka M, Hayashi T, Ito S, Nagafuchi H, JMAAV Study Group et al (2014) Assessment of the Birmingham vasculitis activity score inpatients with MPO-ANCA-associated vasculitis: sub-analysis from a study by the Japanese Study Group for MPO-ANCA-associated vasculitis. Mod Rheumatol 24:304–309CrossRefPubMed Yumura W, Kobayashi S, Suka M, Hayashi T, Ito S, Nagafuchi H, JMAAV Study Group et al (2014) Assessment of the Birmingham vasculitis activity score inpatients with MPO-ANCA-associated vasculitis: sub-analysis from a study by the Japanese Study Group for MPO-ANCA-associated vasculitis. Mod Rheumatol 24:304–309CrossRefPubMed
Metadaten
Titel
Impact of renal involvement on survival in ANCA-associated vasculitis
verfasst von
Manish Rathi
Benzeeta Pinto
Aadhaar Dhooria
Vinay Sagar
Tarun Mittal
Roopa Rajan
Varun Dhir
Susheel Kumar
Kusum Sharma
Ritambhra Nada
Surjit Singh
Ranjana Walker Minz
Aman Sharma
Publikationsdatum
06.06.2016
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 9/2016
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1330-z

Weitere Artikel der Ausgabe 9/2016

International Urology and Nephrology 9/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.